PMCB

PHARMACYTE BIOTECH INC

PMCB·71715X203·US·Common Stock·Healthcare - Biotechnology-13D/G

PMCB (PHARMACYTE BIOTECH INC) is held by 20 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($239,243), GEODE CAPITAL MANAGEMENT, LLC ($130,200), RENAISSANCE TECHNOLOGIES LLC ($37,595). Net institutional sentiment: Mixed.

20
Holders
Avg rating(4 Elite)
$565,591
Total Value
65% (21)
Fund Consensus
11 buying - 6 selling
PMCBSmart Money Verdict
View all
Held by 20 funds
4 elite
Who's Trading
ActivistMPMitchell P. Kopin5.0%Feb 13, 2026
InsiderSJSilverman JoshuaBuy $33KJan 7, 2026
InsiderSJSCHECHTER JONATHANBuy $17KJan 7, 2026
InsiderSJSilverman JoshuaBuy $24KJan 6, 2026
InsiderSJSCHECHTER JONATHANBuy $16KJan 6, 2026
InsiderSJSilverman JoshuaBuy $23KJan 5, 2026
InsiderSJSCHECHTER JONATHANBuy $16KJan 5, 2026
ActivistMPMitchell P. Kopin10.0%Nov 7, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
359,547(+56.5%)$239,2430.0%-3.70%
22
Increased
195,660(+58.0%)$130,2000.0%-63.49%
22
Decreased
56,500(-39.9%)$37,5950.0%-59.91%
0
Increased
52,362(+114.2%)$34,8420.0%-2.06%
32
New
51,467$34,2260.0%-1.41%
30
Unchanged
35,601$23,6890.0%-58.42%
0
Increased
27,009(+3.2%)$17,9710.0%-74.88%
19
New
23,452$15,5960.0%-1.41%
28
Decreased
19,940(-22.8%)$13,2600.0%-4.25%
0
Increased
11,530(+1.2%)$7,6720.0%-2.76%
11
New
10,313$6,8600.0%-1.41%
25
Increased
4,519(+64.6%)$3,0050.0%-19.28%
13
New
1,785$1,1880.0%-1.41%
17
Decreased
302(-0.3%)$2000.0%-34.65%
0
New
37,532$250.0%-1.41%
15
Decreased
24,741(-86.5%)$160.0%-2.78%
0
Decreased
1(-50.0%)$10.0%-35.71%
0
Unchanged
1$10.0%-28.57%
0
Unchanged
2$10.0%-73.24%
0
Unchanged
1$00.0%-98.84%
0

Showing 1-20 of 21

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used